In a filing, Lexicon Pharmaceuticals Inc revealed its Chief Executive Officer COATS LONNEL acquired Company’s shares for reported $94797.0 on Nov 16 ’23. In the deal valued at $1.05 per share,90,000 shares were bought. As a result of this transaction, COATS LONNEL now holds 914,359 shares worth roughly $1.88 million.
Then, COATS LONNEL bought 10,000 shares, generating $10,100 in total proceeds. Upon buying the shares at $1.01, the Chief Executive Officer now owns 824,359 shares.
Before that, DEBBANE RAYMOND bought 148,820 shares. Lexicon Pharmaceuticals Inc shares valued at $153,805 were divested by the Director at a price of $1.03 per share. As a result of the transaction, DEBBANE RAYMOND now holds 1,340,847 shares, worth roughly $2.76 million.
Jefferies initiated its Lexicon Pharmaceuticals Inc [LXRX] rating to a Hold in a research note published on March 07, 2023; the price target was $3. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in mid August with a ‘”an Overweight”‘ rating. JP Morgan also remained covering LXRX and has increased its forecast on January 29, 2021 with a “Neutral” recommendation from previously “an Underweight” rating. Wedbush revised its rating on January 29, 2021. It rated LXRX as “a Neutral” which previously was an “an Outperform”.
Price Performance Review of LXRX
On Friday, Lexicon Pharmaceuticals Inc [NASDAQ:LXRX] saw its stock unchanged to $2.06. Over the last five days, the stock has lost -14.17%. Lexicon Pharmaceuticals Inc shares have risen nearly 34.64% since the year began. Nevertheless, the stocks have fallen -11.97% over the past one year. While a 52-week high of $3.79 was reached on 02/16/24, a 52-week low of $0.92 was recorded on 01/19/24. SMA at 50 days reached $2.37, while 200 days put it at $1.73. A total of 1.23 million shares were traded, compared to the trading of 4.39 million shares in the previous session.
Levels Of Support And Resistance For LXRX Stock
The 24-hour chart illustrates a support level at 2.01, which if violated will result in even more drops to 1.97. On the upside, there is a resistance level at 2.10. A further resistance level may holdings at 2.14. The Relative Strength Index (RSI) on the 14-day chart is 43.29, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 84.13%. Stochastics %K at 14.38% indicates the stock is a buying.
How much short interest is there in Lexicon Pharmaceuticals Inc?
A steep rise in short interest was recorded in Lexicon Pharmaceuticals Inc stocks on Mar 15, 2024, dropping by -2.06 million shares to a total of 21.35 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 23.41 million shares. There was a decline of -9.65%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 14.31% of the overall stock float, the days-to-cover ratio (short ratio) fell to 3.31.
